P16 hypermethylation predicts surgical outcome following curative resection of mid/distal bile duct cancer.

about

P16 hypermethylation predicts surgical outcome following curative resection of mid/distal bile duct cancer.

Item

http://www.wikidata.org/entity/Q50866916

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

P16 hypermethylation predicts ...... f mid/distal bile duct cancer.

@en

P16 hypermethylation predicts ...... f mid/distal bile duct cancer.

@nl

type

Item

label

P16 hypermethylation predicts ...... f mid/distal bile duct cancer.

@en

P16 hypermethylation predicts ...... f mid/distal bile duct cancer.

@nl

prefLabel

P16 hypermethylation predicts ...... f mid/distal bile duct cancer.

@en

P16 hypermethylation predicts ...... f mid/distal bile duct cancer.

@nl

P1476

P16 hypermethylation predicts ...... of mid/distal bile duct cancer

@en

P2093

Jae Keun Kim

http://www.w3.org/2001/XMLSchema#string

Joon Seong Park

http://www.w3.org/2001/XMLSchema#string

Kang Young Lee

http://www.w3.org/2001/XMLSchema#string

Young Nyun Park

http://www.w3.org/2001/XMLSchema#string

P2860

DNA methylation patterns and epigenetic memory

Evaluation of a potential epigenetic biomarker by quantitative methyl-single nucleotide polymorphism analysis

Risk factors for cholangiocarcinoma

Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma.

Epigenetics of kidney cancer and bladder cancer.

Inducible re-expression of p16 in an orthotopic mouse model of pancreatic cancer inhibits lymphangiogenesis and lymphatic metastasis

Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study.

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.

Current research in perineural invasion of cholangiocarcinoma.

Epigenetics in prostate cancer: biologic and clinical relevance.

P2888

s10434-013-2908-7

P304

2511-2517

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-013-2908-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dong S Yoon

P577

2013-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1017669874

http://www.w3.org/2001/XMLSchema#string

P698

23478949

http://www.w3.org/2001/XMLSchema#string